Sodium Zirconium Cyclosilicate (ZS)
D9483C00001
Phase 1 small_molecule completed
Quick answer
Sodium Zirconium Cyclosilicate (ZS) for Hyperkalemia is a Phase 1 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Hyperkalemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed